Form 4: Inari Medical CFO Mitch Hill Executes Stock Options and Sells Shares Under 10b5-1 Plan

Inari Medical's CFO, Mitch C. Hill, exercised stock options and sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On June 12, 2024, Mitch C. Hill, the Chief Financial Officer of Inari Medical, Inc., exercised stock options to acquire 5,000 shares of common stock at a price of $0.457 per share.
• Simultaneously, Hill sold 2,498 shares at a weighted average price of $47.15 and 2,502 shares at a weighted average price of $48.04.
• These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 9, 2023.
• Following these transactions, Hill directly owns 181,294 shares of Inari Medical common stock and indirectly owns 1,600 shares through his spouse.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports routine insider trading activity under a pre-existing plan.

Industry Context

This filing is a routine disclosure of insider transactions and provides transparency to the market regarding the trading activities of company executives.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies, ensuring transparency in insider trading activities.
• The use of a 10b5-1 trading plan is a common method for corporate insiders to sell shares without raising concerns about trading on non-public information, similar to practices at companies like Medtronic or Boston Scientific.

Stakeholder Impact

• The filing provides transparency to shareholders regarding insider trading activities.
• The transactions are unlikely to have a significant impact on employees, customers, suppliers, or creditors.

Key Dates